PBS Biotech
Showcase

Reducing Development Risk For Stem Cell Manufacturing With Scalable Vertical-Wheel Bioreactors

Summary

This presentation, presented at ISSCR Kyoto 2026 explores how Vertical-Wheel Bioreactors can reduce development and manufacturing risk for PSC therapies by providing a scalable platform from process development through commercial production. It highlights global clinical trials supported by Vertical-Wheel technology, predictive scale-down with MiniPRO, controlled hydrodynamics, automation, and linear scale-up through PBS-80. Data demonstrate consistent PSC growth across scales, culminating in >200 billion cells from a 50 L batch while maintaining pluripotency, illustrating a practical pathway from early development to clinical and commercial manufacturing.

This page summarizes the document. The full showcase, including methods, figures and data, is available to view or download with a free account.
Access this documentSign in or create a free account to view the full showcase.
Document details
DocumentShowcaseCell TypeiPSC & PSCSystemsPBS-Mini, PBS-3, PBS-MiniPRO, PBS-80, PBS-15Culture FormatAggregatesPublished2026
Resources

How Can We Help?

Tell us what you need and we’ll take it from there.